Agenix formalizes secondary distribution arrangements for
anti-HBV drug
Receives minimum order for 12 months of RMB28 million (A$4.1
million)
Sinopharm Medicine Holding Co., Ltd (“Sinopharm”), China’s largest pharmaceutical
distribution company, has entered into an agreement with Agenix Bio-Pharmaceutical
(Shanghai) to distribute YouHeDing, Agenix’s anti- hepatitis B virus (“anti-HBV”)
drug, in secondary regional areas in China.
Sinopharm has provided a letter of intent to acquire no less than 400,000 bottles of
YouHeDing with an order value of approximately RMB28 million (A$4.1 million)
within 12 months.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.949M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 45361991 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 6100521 | 8 |
View Market Depth
| Last trade - 09.59am 13/08/2025 (20 minute delay) ? |
| CT1 (ASX) Chart |
Day chart unavailable